Vanguard Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.22B | Buy |
|
|||||
|
2025
Q1 | $3.24B | Buy |
|
|||||
|
2024
Q4 | $3.62B | Sell |
|
|||||
|
2024
Q3 | $3.18B | Buy |
|
|||||
|
2024
Q2 | $5.27B | Buy |
|
|||||
|
2024
Q1 | $6.19B | Buy |
|
|||||
|
2023
Q4 | $5.52B | Buy |
|
|||||
|
2023
Q3 | $4.12B | Sell |
|
|||||
|
2023
Q2 | $5.69B | Buy |
|
|||||
|
2023
Q1 | $5.12B | Buy |
|
|||||
|
2022
Q4 | $4.96B | Buy |
|
|||||
|
2022
Q3 | $3.52B | Buy |
|
|||||
|
2022
Q2 | $3.22B | Buy |
|
|||||
|
2022
Q1 | $5.4B | Buy |
|
|||||
|
2021
Q4 | $5.59B | Buy |
|
|||||
|
2021
Q3 | $5.66B | Buy |
|
|||||
|
2021
Q2 | $4.38B | Buy |
|
|||||
|
2021
Q1 | $3.68B | Buy |
|
|||||
|
2020
Q4 | $3.78B | Sell |
|
|||||
|
2020
Q3 | $4.28B | Buy |
|
|||||
|
2020
Q2 | $4.17B | Buy |
|
|||||
|
2020
Q1 | $2.35B | Buy |
|
|||||
|
2019
Q4 | $1.85B | Buy |
|
|||||
|
2019
Q3 | $1.25B | Buy |
|
|||||
|
2019
Q2 | $1.23B | Sell |
|
|||||
|
2019
Q1 | $1.03B | Sell |
|
|||||
|
2018
Q4 | $1.04B | Buy |
|
|||||
|
2018
Q3 | $1.14B | Buy |
|
|||||
|
2018
Q2 | $677M | Sell |
|
|||||
|
2018
Q1 | $530M | Buy |
|
|||||
|
2017
Q4 | $401M | Buy |
|
|||||
|
2017
Q3 | $340M | Buy |
|
|||||
|
2017
Q2 | $499M | Buy |
|
|||||
|
2017
Q1 | $559M | Buy |
|
|||||
|
2016
Q4 | $378M | Buy |
|
|||||
|
2016
Q3 | $509M | Buy |
|
|||||
|
2016
Q2 | $450M | Buy |
|
|||||
|
2016
Q1 | $369M | Buy |
|
|||||
|
2015
Q4 | $429M | Buy |
|
|||||
|
2015
Q3 | $434M | Buy |
|
|||||
|
2015
Q2 | $393M | Buy |
|
|||||
|
2015
Q1 | $296M | Buy |
|
|||||
|
2014
Q4 | $247M | Buy |
|
|||||
|
2014
Q3 | $174M | Buy |
|
|||||
|
2014
Q2 | $172M | Sell |
|
|||||
|
2014
Q1 | $182M | Buy |
|
|||||
|
2013
Q4 | $143M | Buy |
|
|||||
|
2013
Q3 | $109M | Buy |
|
|||||
|
2013
Q2 | $85M | Buy |
|